Evidence map›Paper›PMID 39873703›Full record

ReviewJNCI cancer spectrum2025

Screening for comprehensive social needs in patients with cancer: a narrative review.

Isabel Arana, Raymond Liu, Lawrence Kushi, Erin Hahn, Meera Ragavan

Abstract readReview
In one paragraph

Review in JNCI cancer spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Treating cancer-related symptoms in patients exhibiting nonmedical opioid use behaviours: a retrospective chart review study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Isabel AranaKaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA 91101, United States.ORCID 0009-0009-9916-5449
Raymond LiuDepartment of Hematology/Oncology, Kaiser Permanente, San Francisco Medical Center, San Francisco, CA 94143, United States.ORCID 0000-0002-4667-9632
Lawrence KushiDivision of Research, Kaiser Permanente Northern California, Pleasanton, CA 94566, United States.ORCID 0000-0001-9136-1175
Erin HahnDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, United States.ORCID 0000-0002-8419-2331
Meera RagavanDepartment of Hematology/Oncology, Kaiser Permanente, San Francisco Medical Center, San Francisco, CA 94143, United States.ORCID 0000-0002-8991-0259

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with cancer who report social needs have worse quality of life, lower health-care access, and suboptimal health outcomes. However, screening for social needs does not happen systematically, and successful screening tools, strategies, and workflows have seldom been described. The downstream effects of screening including resource navigation have also not been well characterized. The objective of this narrative review was to fill these gaps.

methodsTwo investigators searched PubMed and Embase for studies that implemented a patient-facing social screening tool among patients with cancer between 2008 and 2023 using search terms including social screening, social  needs, and cancer.

resultsWe identified 19 articles that met study inclusion criteria. The most common tool used was the validated Health Leads Social Toolkit. Most often, screening tools were administered electronically, sent directly to patients, and captured needs at a single time point during a patient's diagnosis. Screening response rates ranged between 10% and 60%. Less than half of the studies described downstream resource navigation for patients who screened positive for social needs. Only 1 study evaluated the impact of screening on clinical outcomes and quality of life. Screening for patients who do not speak English or who belong to historically racial, ethnic, and gender minority groups was limited.

conclusionsScreening for social needs has been shown to be feasible across delivery systems with numerous validated tools available. However, gaps remain in generalizability to diverse patient populations. Future work must identify how screening workflows can be successfully incorporated into routine clinical workflows.

Indexed as

Mass ScreeningNeeds AssessmentNeoplasmsHealth Services AccessibilityHumansPatient NavigationQuality of LifeSocial Support

Identifiers

PMID39873703
PMCPMC11917213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.